|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Segment Revenue | |
| Sales Of Supplements | |
| Medical Procedures | |
| Sales Of Biologics | |
| Sales Of Ancillary Products | |
| Shipping And Delivery | |
| Services | |
| Supplements | |
| Procedures | |
| Biologics | |
| Total Segment Revenue | |
| Cost of supplements | |
| Gross Profit | |
| General and administrative | |
| Advertising and promotion | |
| Clinical trial fees | |
| Corporate filings | |
| Equipment leases | |
| Legal and professional fees | |
| Licenses | |
| Public relations | |
| Repairs and maintenance | |
| Research and development | |
| Rent | |
| Salaries and wages | |
| Share-Based Payment Arrangement, Noncash Expense | |
| Utilities | |
| Depreciation and amortization | |
| Total Operating Expenses | |
| Profit (Loss) from Operations | |
| Interest income | |
| Sublease income | |
| Interest expense – line of credit (related party) | |
| Total Other Income (Expense) | |
| Net Loss Before Provision for Income Taxes | |
| Provision for Income Taxes | |
| Net Loss | |
| Net Loss Per Share: Basic | |
| Net Loss Per Share: Diluted | |
| Weighted Average Number of Shares Outstanding: Basic | |
| Weighted Average Number of Shares Outstanding: Diluted |
Loading...
